NCT02452320View on ClinicalTrials.gov

Prospective, Double Blind, Placebo Control, Bariatric IV Ace

PHASE4CompletedINTERVENTIONAL

Enrollment

136

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions

Obesity

Interventions

DRUG

intravenous acetaminophen

administration of 1000mg of intravenous acetaminophen or placebo every 6 hours for a total of 4 doses; first dose to be administered after induction of general anesthesia

DRUG

Placebo

Subjects randomized to placebo will receive every 6 hours for a total of 4 doses; first dose to be administered after induction of general anesthesia

Trial Locations (1)

10065

Weill Cornell Medical College, New York

All Listed Sponsors

lead

Weill Medical College of Cornell University

OTHER

NCT02452320 - Prospective, Double Blind, Placebo Control, Bariatric IV Ace | Biotech Hunter | Biotech Hunter